A Madison biotechnology company has signed a multimillion-dollar agreement with the world’s largest pharmaceutical company.
Mirus Bio Corp., founded in 1996 by three UW-Madison researchers, has entered into a two-year deal with Pfizer to work on RNA interference – better known as gene silencing – using two delivery methods.
Office of Strategic Communication